These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease. Opsenica I; Filipovic V; Nuss JE; Gomba LM; Opsenica D; Burnett JC; Gussio R; Solaja BA; Bavari S Eur J Med Chem; 2012 Jul; 53():374-9. PubMed ID: 22516424 [TBL] [Abstract][Full Text] [Related]
17. Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60/70 loop flexibility. Thompson AA; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; Margosiak SA; Johnson AT; Han GW; O'Malley S; Stevens RC Biochemistry; 2011 May; 50(19):4019-28. PubMed ID: 21434688 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies. Šilhár P; Silvaggi NR; Pellett S; Čapková K; Johnson EA; Allen KN; Janda KD Bioorg Med Chem; 2013 Mar; 21(5):1344-8. PubMed ID: 23340139 [TBL] [Abstract][Full Text] [Related]
19. Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A. Jacobson AR; Adler M; Silvaggi NR; Allen KN; Smith GM; Fredenburg RA; Stein RL; Park JB; Feng X; Shoemaker CB; Deshpande SS; Goodnough MC; Malizio CJ; Johnson EA; Pellett S; Tepp WH; Tzipori S Toxicon; 2017 Oct; 137():36-47. PubMed ID: 28698055 [TBL] [Abstract][Full Text] [Related]